Corundum Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Buy |
8,359
+328
| +4% | +$28.6K | 0.32% | 61 |
|
|
2025
Q1 | $722K | Sell |
8,031
-7,996
| -50% | -$719K | 0.35% | 62 |
|
|
2024
Q4 | $1.28M | Buy |
16,027
+8,237
| +106% | +$658K | 0.48% | 59 |
|
|
2024
Q3 | $701K | Sell |
7,790
-2,778
| -26% | -$250K | 0.32% | 63 |
|
|
2024
Q2 | $832K | Buy |
10,568
+4,931
| +87% | +$388K | 0.33% | 68 |
|
|
2024
Q1 | $491K | Buy |
+5,637
| New | +$491K | 0.24% | 70 |
|
|
2023
Q4 | – | Sell |
-9,452
| Closed | -$741K | – | 105 |
|
|
2023
Q3 | $741K | Sell |
9,452
-516
| -5% | -$40.4K | 0.42% | 54 |
|
|
2023
Q2 | $878K | Sell |
9,968
-5,022
| -34% | -$442K | 0.44% | 57 |
|
|
2023
Q1 | $1.21M | Buy |
14,990
+4,894
| +48% | +$395K | 0.57% | 52 |
|
|
2022
Q4 | $785K | Buy |
10,096
+1,004
| +11% | +$78.1K | 0.44% | 62 |
|
|
2022
Q3 | $734K | Buy |
9,092
+2,005
| +28% | +$162K | 0.46% | 54 |
|
|
2022
Q2 | $636K | Buy |
7,087
+681
| +11% | +$61.1K | 0.43% | 63 |
|
|
2022
Q1 | $711K | Buy |
6,406
+2,960
| +86% | +$329K | 0.66% | 59 |
|
|
2021
Q4 | $356K | Buy |
3,446
+1,161
| +51% | +$120K | 0.23% | 78 |
|
|
2021
Q3 | $286K | Sell |
2,285
-134
| -6% | -$16.8K | 0.21% | 80 |
|
|
2021
Q2 | $300K | Buy |
2,419
+108
| +5% | +$13.4K | 0.2% | 76 |
|
|
2021
Q1 | $273K | Buy |
2,311
+80
| +4% | +$9.45K | 0.21% | 73 |
|
|
2020
Q4 | $261K | Buy |
2,231
+64
| +3% | +$7.49K | 0.22% | 72 |
|
|
2020
Q3 | $225K | Buy |
+2,167
| New | +$225K | 0.22% | 73 |
|
|
2020
Q2 | – | Sell |
-2,262
| Closed | -$204K | – | 64 |
|
|
2020
Q1 | $204K | Sell |
2,262
-83
| -4% | -$7.49K | 0.29% | 53 |
|
|
2019
Q4 | $266K | Buy |
2,345
+73
| +3% | +$8.28K | 0.28% | 55 |
|
|
2019
Q3 | $247K | Sell |
2,272
-2
| -0.1% | -$217 | 0.29% | 52 |
|
|
2019
Q2 | $221K | Buy |
2,274
+19
| +0.8% | +$1.85K | 0.25% | 58 |
|
|
2019
Q1 | $205K | Sell |
2,255
-4,363
| -66% | -$397K | 0.23% | 65 |
|
|
2018
Q4 | $602K | Buy |
+6,618
| New | +$602K | 0.55% | 39 |
|